EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dose-resolved untargeted metabolomics of NaB-treated CHO-K1 cells reveals broad catabolic suppression, Warburg-like metabolic reorientation, and coordinated tryptophan pathway alterations as hallmarks of the NaB-responsive state

Rita Singh, Chandra Ratan, Sonu Kumar Gupta, Sankar Bhattacharyya, Shailendra Mani, Pramod Kumar Gautam, Yashwant Kumar, Niraj Kumar

Frontiers in Bioengineering and Biotechnology · 16.11.2026 · 14

DOI: 10.3389/fbioe.2026.1913252 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 16.11.2026. Verfasst von Rita Singh und 7 weiteren Autor:innen. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Biotechnology, Ministry of Science and Technology, India, Council of Scientific and Industrial Research, India.

AbstractBibliografische AngabenZitieren

Abstract (Originalsprache)

Sodium butyrate (NaB) is widely used in Chinese hamster ovary (CHO) cell bioprocessing to enhance recombinant protein productivity, yet the systems-level metabolic consequences of NaB treatment across its pharmacological dose range remain poorly characterised. Here, we performed dose-resolved untargeted liquid chromatography-mass spectrometry (LC-MS)-based metabolomics of CHO-K1 cells treated across eight concentrations of NaB (0–8.0 mM) and identified 469 annotated metabolite features. A ten-stage computational pipeline, comprising probabilistic quotient normalisation, principal component analysis (PCA), differential abundance analysis, Spearman dose-correlation, metabolite set enrichment analysis (MSEA), KEGG topology analysis, Random Forest, Least Absolute Shrinkage and Selection Operator (LASSO) regression, and protein-protein interaction (PPI) network construction, was applied without pathway pre-selection. PCA resolved three concentration-dependent metabolic states: sub-threshold [homeostatic] (0–0.25 mM), NaB-responsive [metabolically reoriented (for growth-arrest and potential increased productivity)] (0.5–2.0 mM), and cytostressed (4.0–8.0 mM). At 2.0 mM, 243 differentially abundant metabolites were identified, with decreased metabolites outnumbering increased ones (152 vs. 91; ratio 1.67:1), indicating broad catabolic suppression and selective activation of (stress regulating) pathways. The most enriched pathways included the Warburg Effect, Tryptophan Metabolism, and Glutamate Metabolism. Dominant metabolic changes comprised decreased abundance of metabolites associated with fatty acid oxidation and amino acid catabolism, alongside concurrent increases in metabolites associated with TCA anaplerosis and the glutathione cycle, patterns consistent with, but not a direct measurement of, altered flux through these pathways. Nine metabolites from tryptophan pathway were coordinately altered, with depletion of indole-derived species and induction of NAD-related metabolites. Machine learning identified Oxoproline, Serine, Heptanoate, Cyclohexanoic Acid, and Indole-3-Lactic Acid as the top candidate dose-responsive biomarkers within this dataset; their predictive performance in independent datasets and their identity have not yet been externally or analytically validated. PPI network analysis identified SIRT1, HDAC1, and IDO1 as the most central regulatory nodes. Together, these findings provide a systems-level metabolic framework for NaB-induced CHO cell physiology and nominate SIRT1, IDO1, CPT1A, and NAMPT as candidate targets for functional validation in recombinant producer cell lines.

Förderung

  • Department of Biotechnology, Ministry of Science and Technology, India
  • Council of Scientific and Industrial Research, India

Zitieren

APA

Singh, R., Ratan, C., Gupta, S. K., Bhattacharyya, S., Mani, S., Gautam, P. K., Kumar, Y., & Kumar, N. (2026). Dose-resolved untargeted metabolomics of NaB-treated CHO-K1 cells reveals broad catabolic suppression, Warburg-like metabolic reorientation, and coordinated tryptophan pathway alterations as hallmarks of the NaB-responsive state. Frontiers in Bioengineering and Biotechnology, 14. https://doi.org/10.3389/fbioe.2026.1913252

Vancouver

Singh R, Ratan C, Gupta SK, Bhattacharyya S, Mani S, Gautam PK, et al. Dose-resolved untargeted metabolomics of NaB-treated CHO-K1 cells reveals broad catabolic suppression, Warburg-like metabolic reorientation, and coordinated tryptophan pathway alterations as hallmarks of the NaB-responsive state. Frontiers in Bioengineering and Biotechnology. 2026;14. doi:10.3389/fbioe.2026.1913252

BibTeX
@article{Singh2026,
  author = {Singh, Rita and Ratan, Chandra and Gupta, Sonu Kumar and Bhattacharyya, Sankar and Mani, Shailendra and Gautam, Pramod Kumar and Kumar, Yashwant and Kumar, Niraj},
  title = {Dose-resolved untargeted metabolomics of NaB-treated CHO-K1 cells reveals broad catabolic suppression, Warburg-like metabolic reorientation, and coordinated tryptophan pathway alterations as hallmarks of the NaB-responsive state},
  journal = {Frontiers in Bioengineering and Biotechnology},
  year = {2026},
  volume = {14},
  doi = {10.3389/fbioe.2026.1913252}
}
Kostenlos starten →